Lupin has secured US FDA approval for Pitolisant tablets ANDA, marking another step in its push into the central nervous system segment.
Somerset Indus Capital Partners oversubscribes Fund III at $288M, targeting healthcare expansion in India’s Tier II & III cities with scalable, impact-driven investments in diagnostics, MedTech, and healthcare delivery.
AHH-owned Nova IVF Fertility is expanding its footprint in Kerala through a strategic acquisition of a 30-year-old, most trusted fertility provider - Craft Fertility.
.png "DrStore Healthcare launched a platform to track outcomes of GLP-1")
DrStore Healthcare Services, a connected healthcare and medical device ecosystem company, through its smart medical devices and tech platform Tracky, has launched an integrated, real-time monitoring platform designed to track patient...
Novartis is preparing to share new clinical findings at the American Academy of Dermatology (AAD) Annual Meeting 2026, focusing on treatments for chronic skin conditions and how patients respond over time.
Droupadi Murmu called for urgent and collective efforts to eliminate Tuberculosis in India ahead of World Tuberculosis Day, stressing that the fight against TB requires strong public participation along with government action.
India’s healthcare sector is feeling the heat of the helium supply crisis; as global disruptions tied to tensions in the Middle East and restricted trade through the Strait of Hormuz begin to push up MRI scan cost and delay installations of...
Pfizer and Valneva have shared encouraging results from a late-stage clinical trial of their Lyme disease vaccine, offering new hope in the fight against a growing health concern.
Godavari Biorefineries Limited has secured a Japan patent for antiviral compounds, marking a fresh step in its expanding life sciences research.
Uttar Pradesh pharma investment is gaining strong momentum as the state moves ahead with a INR2,500 crore plan to build a robust healthcare manufacturing ecosystem.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")